Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

The Stem Cell Program at Children's Hospital Boston Launches New Website Today to Rally Understanding and Support for Promising but Misunderstood Science


News provided by

Children's Hospital Boston

May 10, 2010, 09:01 ET

Share this article

Share toX

Share this article

Share toX

Myth-Busting Primers, Inspiring Patient Stories, Social Media Components, Doctors' Video Tutorials, Scientific Breakthroughs, Ethical Standards, and More

Stemcell.childrenshospital.org

BOSTON, May 10 /PRNewswire-USNewswire/ -- Are stem cells effectively used in human therapies today? Does the ability to reprogram adult stem cells mean we no longer need embryonic stem cell research? Is it true that the stem cells produced through genetic reprogramming may become cancerous? Embryonic stem cells are said to have so much promise, but when will they lead to cures?

These questions are just some of those mostly frequently asked by a confused public searching for answers, according to the doctors and researchers at the world-renowned Stem Cell Program at Children's Hospital Boston -- and they are among the primary reasons for launching today a new website: stemcell.childrenshospital.org.

The pediatric teaching hospital for Harvard Medical School, Children's Hospital Boston has long been a leader in stem cell research, contributing many breakthroughs to the field. Now, in addition to its commitment to advancing the science, the Stem Cell Program at Children's seeks to engage the public in a national discussion on the crucial need to support stem cell research, still a hot-button topic for some.  By creating the new website, Children's aims to fill a void and become the go-to resource for reliable and accessible information on the often misconstrued field of stem cell research. The ultimate goal: to bring stem cell-based therapies to the clinic within a matter of years in order to usher in a new era of cost effective healing that is non-invasive to patients.

"When it comes to stem cells, there is still a high level of misunderstanding or confusion on the part of the general public," said Dr. Leonard Zon, Director of the Stem Cell Program at Children's Hospital Boston. "Our goal with this site is to be a reliable source of stem cell-related information and to encourage people to become vested in the science and actively involved in furthering what we consider to be the most exciting and promising field of medical research."

Designed to be a consumer-friendly resource, the new site seeks to explain the science in readily understandable terms, to correct misperceptions, and to illuminate the power and value of different types of stem cells to create potential cures for a range of diseases -- including heart disease, diabetes, leukemia and other cancers, sickle cell anemia, neurologic disorders, such as Parkinson's and Huntington's, muscular disorders, such as muscular dystrophy, and much more.

"The goal of our research is one day to be able to cure what is now incurable," said Dr. George Daley, Director of Stem Cell Transplantation at Children's Hospital Boston.  "With the new stem cell website and social media applications, those of us on the front lines can communicate directly with the public and those who could benefit from these potential therapies -- and we can convey what progress is being made, what the ongoing challenges are, and what can be done to help fund research and find cures."

To further engage the public, the Children's Hospital Boston Stem Cell Program is taking an interactive approach to promote a national conversation on stem cells through an ambitious social media presence, which will be facilitated by these other digital interfaces newly created and hosted by the Stem Cell Program:

Facebook Page: http://www.facebook.com/BostonStemCell

YouTube Channel: http://www.youtube.com/BostonStemCell

Twitter: @BostonStemCell (http://www.twitter.com/BostonStemCell).  

Moreover, the Stem Cell Program's leaders, Dr. Leonard Zon and Dr. George Daley, will provide trenchant commentary and research updates on new personal Twitter accounts: @leonard_zon and @G_Q_Daley.

In terms of website content, the visually captivating site features a series of 3-D animated "stem cell 101" videos, hosted by Dr. Zon and Dr. Daley, which address some of the most frequently asked questions about stem cells and give viewers a visual tutorial.  Other areas on the site provide a history of the science of stem cells and the policies impacting research, a primer on the ethical debates surrounding stem cell research, a newsroom featuring updates on the latest breakthroughs in the field, and more.

Courageous Patients

The new website will also give people a chance to see the human face of stem cell science.  For instance, in an inspiring video, the parents of young Andy Trevino talk about turning to Children's Hospital Boston for life-saving stem cell treatment to save their son.  They speak candidly about using in-vitro fertilization to conceive a "savior sibling," a sister who would be a donor-match for a blood stem cell transplant. Compelling videos show Andy's transformation from a terminally-ill toddler to the happy, healthy and active child he is today, thanks to healthy stem cells harvested from the cord blood of his little sister Sofia, which were successfully transplanted to Andy. The Trevinos also talk about their decision to donate rather than discard the leftover embryos from the IVF process to help further the research in Dr. Daley's lab.

Visitors will also meet Barry Siegel, an incredibly dynamic personality and avid cycling enthusiast in his 50s who was struck by a car while bike riding five summers ago -- an accident that rendered him paralyzed from the neck down.  Siegel has donated his own cells and has personally raised considerable funds to promote stem cell research that could one day benefit those suffering from spinal cord injuries. Other patient stories will also be added to the website over time -- including that of a gifted teenaged sickle-cell anemia patient who spent the summer working in Dr. Daley's lab on research that could one day yield a cure for his own painful illness.

State of Research

In the "Research on Diseases" section of the website, patients and family members interested in finding out about the research status on specific diseases can learn about the latest progress or obstacles with regard to stem cell research targeting diseases ranging from heart disease to cancer to diabetes, and more.  They can also find out ways to become involved and how individuals can help. This area of the site also cautions patients about the dangers of pursuing untested experimental stem cell treatments that could do more harm than good, and offers valuable information on guidelines and how to distinguish reputable research by accredited institutions from bogus treatments or medical tourism scams.

A Unique Plan

The new website also spells out the unique plan for reaching human trials. The Stem Cell Program at Children's Hospital has teamed up some of the best minds in science and medicine with some of the most influential leaders in business to move the field forward.  "Through my experience in business and sports, I've learned that a well thought out game plan provides a much greater opportunity to execute and win," said Jonathan Kraft, President of The Kraft Group and the New England Patriots, who chairs the stem cell task force at Children's with his wife, Patti. "We are right on the cusp of developing cost-effective stem cell therapies, and the Children's Stem Cell Program has the right plan to take us from research to treatment," he said.  "This new website is a way to educate and galvanize business leaders, policy makers, the media, and individuals to help America lead the way in developing real therapies for millions of patients around the world."

Children's Hospital Boston is home to the world's largest research enterprise based at a pediatric medical center, where its discoveries have benefited both children and adults since 1869. More than 500 scientists, including eight members of the National Academy of Sciences, 11 members of the Institute of Medicine and 13 members of the Howard Hughes Medical Institute comprise Children's research community. Founded as a 20-bed hospital for children, Children's Hospital Boston today is a 397-bed comprehensive center for pediatric and adolescent health care grounded in the values of excellence in patient care and sensitivity to the complex needs and diversity of children and families. Children's also is the primary pediatric teaching affiliate of Harvard Medical School. For more information about the hospital and its research visit: www.childrenshospital.org/newsroom.

CONTACTS:

Eileen Campion / 212.966.4600 / [email protected]


Rob Graham, Public Affairs, Children's Hospital Boston

617.919. 3111 / [email protected]

SOURCE Children's Hospital Boston

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.